ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12 | +9.1% | 825 | 0.0% | 0.00% | – |
| Q1 2024 | $11 | -54.2% | 825 | -62.5% | 0.00% | – |
| Q4 2023 | $24 | -79.3% | 2,200 | -79.2% | 0.00% | -100.0% |
| Q3 2023 | $116 | -4.9% | 10,574 | +14.7% | 0.00% | 0.0% |
| Q2 2023 | $122 | -11.6% | 9,217 | -9.4% | 0.00% | 0.0% |
| Q1 2023 | $138 | -35.5% | 10,169 | -7.2% | 0.00% | -50.0% |
| Q4 2022 | $214 | -99.9% | 10,960 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $209,000 | +5.0% | 10,960 | +13.5% | 0.00% | 0.0% |
| Q2 2022 | $199,000 | -30.9% | 9,656 | +7.9% | 0.00% | 0.0% |
| Q1 2022 | $288,000 | – | 8,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |